Form 4 Tracker
PTC THERAPEUTICS, INC.
PTCT

27 insider filings · Latest: Jun 26, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 8, 2026May 8 8:15 PMBoulding Mark Elliott
Proposed Sale
3,540$78.97$279.6K

View →

Apr 21, 2026Apr 23 9:20 PMMatthew B. KleinDirector, CHIEF EXECUTIVE OFFICER
Sale
2,850$70.91$202.1K394,070(D)

View →

Apr 21, 2026Apr 21 8:12 PMKlein Matthew B.
Proposed Sale
2,850$70.94$202.2K

View →

Apr 6, 2026Apr 8 9:20 PMMark Elliott BouldingEXEC. VP AND CLO
Sale
2,265$69.45$157.3K105,212(D)

View →

Apr 2, 2026Apr 6 9:20 PMLee Scott GoldenEVP & CHIEF MEDICAL OFFICER
Sale
829$67.99$56.4K79,115(D)

View →

Apr 6, 2026Apr 6 8:13 PMBoulding Mark Elliott
Proposed Sale
2,265$69.44$157.3K

View →

Apr 1, 2026Apr 3 9:20 PMNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER
Sale
52,003$69.04$3.6M60,137(D)

View →

Apr 2, 2026Apr 2 7:32 PMGolden Lee Scott
Proposed Sale
829$67.99$56.4K

View →

Apr 1, 2026Apr 1 8:46 PMAlmstead Neil Gregory
Proposed Sale
52,003$69.04$3.6M

View →

Mar 12, 2026Mar 13 9:20 PMMatthew B. KleinDirector, CHIEF EXECUTIVE OFFICER
Sale
2,662$64.08$170.6K396,920(D)

View →

Mar 10, 2026Mar 12 9:20 PMStephanie OkeyDirector
Sale
15,167$70.00$1.1M8,000(D)

View →

Mar 12, 2026Mar 12 7:23 PMKlein Matthew B.
Proposed Sale
2,662$64.08$170.6K

View →

Mar 10, 2026Mar 10 6:12 PMOkey Stephanie
Proposed Sale
15,167$70.00$1.1M

View →

Mar 5, 2026Mar 9 9:20 PMStephanie OkeyDirector
Sale
6,333$63.38$401.4K8,000(D)

View →

Mar 5, 2026Mar 9 9:20 PMLee Scott GoldenEVP & CHIEF MEDICAL OFFICER
Sale
10,000$63.38$633.8K79,944(D)

View →

Mar 5, 2026Mar 9 9:20 PMNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER
Sale
3,989$63.38$252.8K2,737(I)

View →

Mar 5, 2026Mar 5 6:41 PMOkey Stephanie
Proposed Sale
6,333$63.38$401.4K

View →

Mar 5, 2026Mar 5 4:40 PMAlmstead Zheng Yang
Proposed Sale
3,989$63.38$252.8K

View →

Mar 5, 2026Mar 5 4:16 PMGolden Lee Scott
Proposed Sale
10,000$63.38$633.8K

View →

Feb 19, 2026Feb 23 10:20 PMMark Elliott BouldingEXEC. VP AND CLO
Sale
3,019$69.48$209.8K105,212(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 26, 2026Jun 30 9:20 PMNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER
Option Exercise
8,130$38.1019,687(D)

View →

Jun 25, 2026Jun 26 9:20 PMNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER
Option Exercise
20,960$39.4236,150(D)

View →

Jun 24, 2026Jun 26 9:20 PMNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER
Option Exercise
5,323$38.1048,677(D)

View →

Jun 22, 2026Jun 24 9:20 PMNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER
Option Exercise
23,749$25.6923,751(D)

View →

Jun 17, 2026Jun 22 9:20 PMChristine Marie UtterSVP, CHIEF ACCOUNTING OFFICER
Option Exercise
19,686$25.6915,314(D)

View →

Jun 17, 2026Jun 22 9:20 PMMark Elliott BouldingEXEC. VP AND CLO
Option Exercise
10,522$46.5430,938(D)

View →

Jun 10, 2026Jun 12 9:30 PMEric PauwelsCHIEF BUSINESS OFFICER
Sale
17,566$18.010(D)

View →

May 15, 2026May 19 9:20 PMMark Elliott BouldingEXEC. VP AND CLO
Option Exercise
2,812$25.6919,689(D)

View →

May 8, 2026May 12 9:20 PMMark Elliott BouldingEXEC. VP AND CLO
Option Exercise
3,540$46.5441,460(D)

View →

Apr 6, 2026Apr 8 9:20 PMMark Elliott BouldingEXEC. VP AND CLO
Option Exercise
2,265$39.426,798(D)

View →

Mar 24, 2026Mar 26 11:41 PMJessica Caroline ChutterDirector
Grant/Award
6,371$64.542,896(D)

View →

Mar 10, 2026Mar 12 9:20 PMStephanie OkeyDirector
Option Exercise
15,167$33.630(D)

View →

Feb 17, 2026Feb 19 10:25 PMMark Elliott BouldingEXEC. VP AND CLO
Option Exercise
2,813$25.6922,501(D)

View →